Camurus AB
Camurus AB
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An Observational Study of Octreotide Subcutaneous Depot in Patients With Acromegaly | Bone Diseases, Endocrine, acromegaly, bone disorder, brain disorder, central nervous system disorder, endocrine system disorder, hyperpituitarism, hypothalamic disorder, musculoskeletal system disorder, nervous system disorder, pituitary gland disorder | Recruiting | Not stated | 2026-09-25 | NCT07583563 | |
| A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET | digestive system neuroendocrine neoplasm | Active, not recruiting | Phase 3 | 2026-07-28 | NCT05050942 | |
| A Trial to Assess the Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With PLD | Abnormalities, Multiple, Ciliopathies, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autosomal dominant polycystic kidney disease, autosomal dominant polycystic liver disease, cystic kidney disease, hereditary disease, kidney disorder, polycystic kidney disease, urinary system disorder | Active, not recruiting | Phase 2 / Phase 3 | 2026-06-01 | NCT05281328 |